New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Long-acting injectable ART superior to standard care for poorly adherent people with HIV

Long-acting injectable ART superior to standard care for poorly adherent people with HIV

by Elana GotkineFor people with HIV (PWH) and a history of suboptimal adherence to antiretroviral therapy, long-acting injectable treatment with cabotegravir and rilpivirine (LAI) is superior to oral
Public Health & Prevention March 20,2024
Long-acting injectable ART superior to standard care for poorly adherent people with HIV

Long-acting injectable ART superior to standard care for poorly adherent people with HIV

by Elana GotkineFor people with HIV (PWH) and a history of suboptimal adherence to antiretroviral therapy, long-acting injectable treatment with cabotegravir and rilpivirine (LAI) is superior to oral
Public Health & Prevention March 20,2024
Evaluating outcomes of extended thrombolytic therapy for ischemic stroke

Evaluating outcomes of extended thrombolytic therapy for ischemic stroke

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainThrombolytic therapy administered longer after the onset of ischemic stroke than current recommendations did not demonst
Neurology March 20,2024
Evaluating outcomes of extended thrombolytic therapy for ischemic stroke

Evaluating outcomes of extended thrombolytic therapy for ischemic stroke

by Melissa Rohman,Northwestern UniversityCredit: Pixabay/CC0 Public DomainThrombolytic therapy administered longer after the onset of ischemic stroke than current recommendations did not demonst
Neurology March 20,2024
'Study drugs' shown to set the stage for other drug use and mental health decline

'Study drugs' shown to set the stage for other drug use and mental health decline

by Binghamton UniversityCredit: Pixabay/CC0 Public DomainTaking "study drugs" like Adderall without a diagnosis is not only dangerous in itself but can lead to other drug use and a decl
Breakthroughs March 20,2024
'Study drugs' shown to set the stage for other drug use and mental health decline

'Study drugs' shown to set the stage for other drug use and mental health decline

by Binghamton UniversityCredit: Pixabay/CC0 Public DomainTaking "study drugs" like Adderall without a diagnosis is not only dangerous in itself but can lead to other drug use and a decl
Breakthroughs March 20,2024
New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment

New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment

by European Association for the Study of ObesityCredit: Unsplash/CC0 Public DomainTirzepatide, a medication authorized to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardle
Diabetes & Endocrinology March 20,2024
New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment

New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment

by European Association for the Study of ObesityCredit: Unsplash/CC0 Public DomainTirzepatide, a medication authorized to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardle
Diabetes & Endocrinology March 20,2024
Could ADHD drugs reduce the risk of early death? Unpacking the findings from a new Swedish study

Could ADHD drugs reduce the risk of early death? Unpacking the findings from a new Swedish study

by Hassan Vally,The ConversationCredit: Pixabay/CC0 Public DomainAttention-deficit hyperactivity disorder (ADHD) can have a considerable impact on the day-to-day functioning and overall well-bei
Breakthroughs March 20,2024
Could ADHD drugs reduce the risk of early death? Unpacking the findings from a new Swedish study

Could ADHD drugs reduce the risk of early death? Unpacking the findings from a new Swedish study

by Hassan Vally,The ConversationCredit: Pixabay/CC0 Public DomainAttention-deficit hyperactivity disorder (ADHD) can have a considerable impact on the day-to-day functioning and overall well-bei
Breakthroughs March 20,2024
Poor trial results may prompt maker to pull ALS drug from market

Poor trial results may prompt maker to pull ALS drug from market

by Robin FosterFollowing disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.In astatementissued Friday, Amylyx Pharmaceuticals said t
Breakthroughs March 20,2024
Poor trial results may prompt maker to pull ALS drug from market

Poor trial results may prompt maker to pull ALS drug from market

by Robin FosterFollowing disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market.In astatementissued Friday, Amylyx Pharmaceuticals said t
Breakthroughs March 20,2024
Anxiety drug pregabalin is linked to a rising number of deaths. Here's what you should know

Anxiety drug pregabalin is linked to a rising number of deaths. Here's what you should know

by Ian Hamilton and Harry Sumnall,The ConversationCredit: Pixabay/CC0 Public DomainThere has been a significant rise in deaths linked to the commonly prescribed anxiety drug, pregabalin. While i
Breakthroughs March 20,2024
Anxiety drug pregabalin is linked to a rising number of deaths. Here's what you should know

Anxiety drug pregabalin is linked to a rising number of deaths. Here's what you should know

by Ian Hamilton and Harry Sumnall,The ConversationCredit: Pixabay/CC0 Public DomainThere has been a significant rise in deaths linked to the commonly prescribed anxiety drug, pregabalin. While i
Breakthroughs March 20,2024
Exploring how the liver immune system eats up 'bad cholesterol'

Exploring how the liver immune system eats up 'bad cholesterol'

by Karolinska InstitutetCredit: CC0 Public DomainA new study from Karolinska Institutet in Sweden reveals that immune cells in the liver react to high cholesterol levels and eat up excess cholest
Hepatobiliary&Pancreas Surgery March 20,2024
Exploring how the liver immune system eats up 'bad cholesterol'

Exploring how the liver immune system eats up 'bad cholesterol'

by Karolinska InstitutetCredit: CC0 Public DomainA new study from Karolinska Institutet in Sweden reveals that immune cells in the liver react to high cholesterol levels and eat up excess cholest
Hepatobiliary&Pancreas Surgery March 20,2024
The TREM2 antibody: A new player in atherosclerosis

The TREM2 antibody: A new player in atherosclerosis

by Kirstin Linkamp, Universitätsklinikum WürzburgTreatment with the agonistic TREM2 antibody 4D9 leads to the formation of smaller necrotic cores (red outlines) in atherosclerotic plaques of the aorti
Cardiovascular Diseases March 20,2024
The TREM2 antibody: A new player in atherosclerosis

The TREM2 antibody: A new player in atherosclerosis

by Kirstin Linkamp, Universitätsklinikum WürzburgTreatment with the agonistic TREM2 antibody 4D9 leads to the formation of smaller necrotic cores (red outlines) in atherosclerotic plaques of the aorti
Cardiovascular Diseases March 20,2024
Artificial intelligence detects heart defects in newborns

Artificial intelligence detects heart defects in newborns

by Vanessa Bleich,ETH ZurichPediatric cardiologist Dr. Holger Michel during a cardiac ultrasound examination of 7-week-old Jarmo in the presence of his mother. Credit: Sven Wellmann / KUNO Klini
Cardiovascular Diseases March 20,2024
Artificial intelligence detects heart defects in newborns

Artificial intelligence detects heart defects in newborns

by Vanessa Bleich,ETH ZurichPediatric cardiologist Dr. Holger Michel during a cardiac ultrasound examination of 7-week-old Jarmo in the presence of his mother. Credit: Sven Wellmann / KUNO Klini
Cardiovascular Diseases March 20,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com